Andre Goy, MD, is Featured among America's Top Doctors in Medical Oncology in 2015

    HACKENSACK, NJ, June 19, 2015 /24-7PressRelease/ -- Andre Goy, MD, has been recognized for his dedication, leadership and excellence in health care. With nearly three decades of significant contributions to the field of health care, Andre Goy, MD, is an internationally recognized oncologist and researcher specializing in blood cancers, particularly lymphomas.

Dr. Goy is currently the Chairman of Oncology, Cancer Center Director, Head of Lymphoma Division, and Clinical and Translational Research at John Theurer Cancer Center at Hackensack University Medical Center. John Theurer Cancer Center is ranked among the Top 50 cancer centers nationwide, among the Top 3 in the NY Metro area and #1 in New Jersey. JTCC physicians are highly subspecialized with 14 divisions just in adult oncology plus radiation, pediatric oncology and surgical oncology. JTCC has a strong expertise in blood cancers and bone marrow transplantation with close to 6000 bone marrow transplantations performed so far and strong clinical research, which translated into more than 500 publications over the last 5 years. Dr. Goy's interest has been in lymphoma and particularly novel therapies and immunotherapy.

In 2011, Dr. Goy was named chairman and director of John Theurer Cancer Center at Hackensack University Medical Center. Dr. Goy has led international research and patient empowerment initiatives for the Center as deputy director and chief of lymphoma since 2005. He is also the chief science officer and director of research and innovation of Regional Cancer Care Associates (RCCA), a statewide oncology network. Dr. Goy's award-winning research was funded by the Susan Vaughan Foundation for Translational Research in Lymphoma, The Fishman Foundation, The Cure for Cancer Schechter Foundation as well as through multiple research collaborations with industry and the U.S. Food and Drug Administration. In addition, he is frequently invited to speak and teach around the world and has authored more than 120 publications including in the most prestigious oncology journal (Blood, Journal of Clinical Oncology) as well as in The New England Journal of Medicine. He is a journal reviewer for multiple medical publications, including Cancer, Blood, Journal of Clinical Oncology and Clinical Cancer Research, among others. He is an internationally-renowned clinician and researcher specialized in lymphoma, with a particular interest in aggressive lymphomas and mantle cell lymphomas.

Dr. Goy has trained and worked at the world's leading medical institutions including Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, University Hospital Alliance Assistance Publique in Paris as well as Gustave Roussy Institute Cancer Center and the Pasteur Institute in Paris as well. He was instrumental in developing John Theurer Cancer Center's Tissue Bank, where samples of cells, tissue, and other anatomical structures are stored and analyzed for research purposes.

Dr. Goy's training includes a Master of Science in immunology from Paris Pasteur Institute and a Master of Science in experimental oncology from the University Marie Curie in Paris, France. He completed a fellowship in hematology and oncology at University Joseph Fourier Medical Center in Grenoble and a post-doctoral fellowship in molecular oncology at Sloan Kettering Cancer Center. Continued education has earned him board certifications in internal medicine, hematology and medical oncology. Dr. Goy has consistently been recognized by the professional medical community and patients alike for his leadership and dedication, as he has consistently been featured among America's Top Doctors In Medical Oncology, America's Top Doctors for Cancer and Medical Oncology, and Top Doctors in the New York Metro Area in Medical Oncology by Castle Connolly Medical Ltd. Dr. Goy has been the recipient of the Patients' Choice Award and was voted as one of New Jersey's Top 10 Medical Oncologists in 2014. He also received Compassionate Doctor Recognition from 2010 to 2013. In the coming years, Dr. Goy is committed to growing John Theurer Cancer Center as a place of discovery. Dr. Goy is on the board of COTA (Cancer Outcome Tracking Analysis), an outcome database platform which he helped co-found. "We are undergoing an unprecedented revolution in the field of oncology, both from the diagnostic and therapeutic standpoints" and "COTA will help guide decisions by allowing to stratify patients, better allowing to deliver personalized therapies hence smarter medicine," remarked Dr. Goy.

For more information about John Theurer Cancer Center at Hackensack University Medical Center, please visit http://jtcancercenter.org.

# # #